Full Text View
Tabular View
No Study Results Posted
Related Studies
Manhattan HIV/Hepatology Brain Bank
This study is currently recruiting participants.
Verified by Mount Sinai School of Medicine, March 2006
First Received: March 7, 2006   No Changes Posted
Sponsors and Collaborators: Mount Sinai School of Medicine
National Institute of Mental Health (NIMH)
Information provided by: Mount Sinai School of Medicine
ClinicalTrials.gov Identifier: NCT00300209
  Purpose

Description: The Manhattan HIV/Hepatology Brain Bank (MHBB) was established in 1998 as a resource for the AIDS research community. The MHBB was created to act as a center for the provision of pre- and post-mortem tissues and body fluids from HIV infected persons. It has recently expanded its goals to assist in the elucidation of liver disease-induced nervous system disorders.

The MHBB is dedicated to improving the understanding of HIV and Hepatitis C and thereby, improving the lives of patients living with HIV and/or Hepatitis C.

Participation is voluntary and can be stopped at any time.

Benefits: This is an observational study; no experimental procedures, devices or drugs are used. All enrolled patients undergo regular examinations by physicians, nurses, and neuropsychologists who specialize in the problems that HIV and HCV can cause.

Taking part in this study may result in the detection of brain, muscle, or spinal cord disease for which treatments may be available. Participants may receive no direct benefit from this study. However, knowledge gained from this research may, in the future, help others who suffer from HIV/AIDS and/or liver disease. Participants agree to autopsy and organ donation upon demise by signing an Anatomical Gift Consent document.


Condition Intervention
HIV
Hepatitis
Behavioral: Neuropsycologogical Testing

MedlinePlus related topics: AIDS Hepatitis Liver Diseases
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study
Official Title: Manhattan HIV/Hepatology Brain Bank

Further study details as provided by Mount Sinai School of Medicine:

Study Start Date: September 1998
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

CD4 < 50 on two occasions >12 weeks apart. Hemoglobin <10 G/dL. Albumin <3.2 G/dL.

CMV end-organ disease Disseminated MAC PML AIDS Dementia Complex Wasting (>30% of lean body mass)

Visceral Kaposi's sarcoma Lymphoma-systemic of CNS

CHF Major systemic illness with poor prognosis (as determined by primary physician).

Exclusion Criteria:

- <18 years old Not willing to sign an Anatomical Gift Consent for autopsy and organ donation upon demise.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00300209

Contacts
Contact: Anita Rau 212 241-3691 anita.rau@mssm.edu

Locations
United States, New York
Mount Sinai School of Medicine Recruiting
New York, New York, United States, 10029
Sponsors and Collaborators
Mount Sinai School of Medicine
Investigators
Principal Investigator: Susan Morgello, MD Mount Sinai School of Medicine
  More Information

No publications provided

Study ID Numbers: MH059724, 98-0477
Study First Received: March 7, 2006
Last Updated: March 7, 2006
ClinicalTrials.gov Identifier: NCT00300209     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Hepatitis
Liver Diseases
Digestive System Diseases
HIV Infections
Acquired Immunodeficiency Syndrome

Additional relevant MeSH terms:
Hepatitis
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 07, 2009